BeiGene
BGNE
#976
Rank
S$27.16 B
Marketcap
$248.31
Share price
0.49%
Change (1 day)
10.08%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company